Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.46 |
| ▸ | CFTR | P13569 | 1/20 | 0.43 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8274960 | 1.00 | CTRC (0.61) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL10017610 | 0.89 | CTRC (0.47) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL29694490 | 0.89 | CTRC (0.54) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL11317303 | 0.86 | ALDH1A1 (0.47) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL12664899 | 0.81 | CTRC (0.44) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL192372 | 0.80 | CTRB1 (0.63) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL6755504 | 0.80 | CTRC (0.57) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL11755274 | 0.80 | CTRC (0.57) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL13838039 | 0.80 | CTRC (0.45) | CTRCALDH1A1GAAALDH2HPGD | |
| SCHEMBL3246904 | 0.80 | ALDH1A1 (0.55) | ALDH1A1ALDH2HPGDSIRT2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1798 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3947517-B1 | MULTI-AMINE DISPERSANT MADE VIA AN ANHYDRIDE INTERMEDIATE AND PROCESS FOR THE PREPARATION THEREOF | LUBRIZOL ADVANCED MAT INC (US) | 2025-10-15 | — | — | EP | claimed |
| US-12338361-B2 | Multi-amine polyester dispersant made via an anhydride intermediate | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-06-24 | — | — | US | claimed |
| US-20250176537-A1 | POLYESTER-POLYETHER SOLID ARTICLE COMPRISING PHEROMONE | THE PROCTER & GAMBLE COMPANY | 2025-06-05 | — | — | US | claimed |
| US-20250177597-A1 | POLYESTER-POLYETHER SOLID ARTICLE COMPRISING HYDROPHOBIC MATERIAL | THE PROCTER & GAMBLE COMPANY | 2025-06-05 | — | — | US | claimed |
| CN-120059532-A | Water-based on-rust paint for steel structure and preparation method thereof | 河北冀中漆业股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119332508-B | Composite high-temperature-resistant material containing glass fiber yarns and preparation method thereof | 淄博安盾新材料有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-117801596-B | Photosensitive polyimide resin composition and preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2025-04-25 | — | — | CN | claimed |
| CN-118878952-B | New energy automobile tread rubber with wear resistance and high ground grabbing force and preparation method thereof | 山东华盛橡胶有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119798627-A | Method for preparing hydroxyl-terminated high molecular polyester polyol without metal catalyst and polyester polyol | 北京高盟新材料股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118852022-B | Gemini quaternary ammonium salt antibacterial agent, preparation thereof and application thereof in antibacterial polyester synthesis | 浙江大学 | 2025-03-28 | — | — | CN | claimed |
| US-6326122-B1 | HEAT SENSITIVE ELEMENTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-12-04 | — | — | US | claimed |
| US-6180739-B1 | CYCLODEXTRINS WITH ACRYLATE AND ANHYDRIDES | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION | 2001-01-30 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5929131-A | Polymerizable cyclodextrin derivatives | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5792821-A | Polymerizable cyclodextrin derivatives | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1998-08-11 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250176537-A1 | POLYESTER-POLYETHER SOLID ARTICLE COMPRISING PHEROMONE | PGRMC2, PGRMC1, PUF60 | CTRC 1916/4885ALDH1A1 3695/4885GAA 3766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.